MedPath
HSA Approval

NOVAFLOX EYE DROPS 3 mg/ml

SIN13175P

NOVAFLOX EYE DROPS 3 mg/ml

NOVAFLOX EYE DROPS 3 mg/ml

January 17, 2006

PETER CHIA MARKETING PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPETER CHIA MARKETING PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01AX13

xs 01 ax 13

Manufacturer Information

PETER CHIA MARKETING PTE. LTD.

Ashford Laboratories Ltd

Active Ingredients

CIPROFLOXACIN HCl EQV CIPROFLOXACIN

3.0 mg/ml

Ciprofloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NOVAFLOX EYE DROPS 3 mg/ml - HSA Approval | MedPath